Role of radiotherapy in the management of node-positive prostate cancer

被引：2
|
作者：
Supiot, S. [1 ]
Dore, M. [1 ]
Rio, E. [1 ]
Cellier, P. [1 ]
Mesguez-Nebout, N. [1 ]
Goineau, A. [1 ]
机构：
[1] Inst Cancerol Ouest Rene Gauducheau, Dept Radiotherapie, Blvd Jacques Monod, F-44805 St Herblain, France
来源：
CANCER RADIOTHERAPIE | 2016年 / 20卷 / 6-7期
关键词：
Prostate adenocarcinoma; pN1; cN1; N1; Metastatic prostate cancer; Oligometastases; Irradiation; Pelvis; Androgen depriving therapy; Hormonetherapy; RADIATION-THERAPY; RADICAL PROSTATECTOMY; ADJUVANT; FAILURE;
D O I：
10.1016/j.canrad.2016.06.002
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Node-positive prostate cancer patients represent a small proportion of all prostate cancers for whom limited prospective information is available. Most retrospective or cohort data strongly suggest however that radiotherapy combined with androgen-depriving therapies is the preferable treatment in this setting. Only randomized clinical trials would be able to better define both radiotherapy (dose? volume? fractionation?) and androgen-depriving therapies (duration? role of novel androgen-depriving therapy?) modalities. (C) 2016 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码：442 / 444
页数：3
相关论文
共 50 条
  • [31] Androgen deprivation therapy in men with node-positive prostate cancer treated with postoperative radiotherapy
    Bravi, Carlo Andrea
    Tin, Amy
    Vertosick, Emily
    Mazzone, Elio
    Bandini, Marco
    Dell'Oglio, Paolo
    Stabile, Armando
    Gandaglia, Giorgio
    Fossati, Nicola
    Sjoberg, Daniel
    Touijer, Karim
    Cozzarini, Cesare
    Briganti, Alberto
    Montorsi, Francesco
    Eastham, James
    Vickers, Andrew
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (04) : 204 - 209
  • [32] Impact of prostate radiotherapy on survival outcomes in clinically node-positive prostate cancer: A multicentre retrospective analysis
    Elumalai, Thiraviyam
    Maitre, Priyamvada
    Portner, Robin
    Mariam, Neethu Billy Graham
    Young, Tom
    Hughes, Simon
    Wickramasinghe, Kanchana
    Bhana, Rajanee
    Sabar, Muhammad
    Jayaprakash, Kamalram Thippu
    Mistry, Hitesh
    Hoskin, Peter
    Choudhury, Ananya
    RADIOTHERAPY AND ONCOLOGY, 2023, 186
  • [33] Radiotherapy or surgery for the axilla in node-positive breast cancer?
    Farace, Paolo
    Deidda, Maria Assunta
    Amichetti, Maurizio
    LANCET ONCOLOGY, 2015, 16 (02): : E53 - E54
  • [34] Surgical Management of Node-positive Prostate Cancer: Perspectives from Breast Oncology
    Kennecke, Hagen F.
    Keyes, Mira
    EUROPEAN UROLOGY, 2014, 66 (02) : 202 - 203
  • [35] Role of Androgen Deprivation Therapy for Node-Positive Prostate Cancer Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (03): : 972 - 973
  • [36] Management of the neck in node-positive tonsillar cancer
    Marklund, Linda
    Lundberg, Bertil
    Hammarstedt-Nordenvall, Lalle
    ACTA OTO-LARYNGOLOGICA, 2014, 134 (10) : 1094 - 1100
  • [37] Prognostic factors in lymph node-positive prostate cancer
    Hofer, Matthias D.
    Kuefer, Rainer
    Huang, Wei
    Li, Haojie
    Bismar, Tarek A.
    Perner, Sven
    Hautmann, Richard E.
    Sanda, Martin G.
    Gschwend, Juergen E.
    Rubin, Mark A.
    UROLOGY, 2006, 67 (05) : 1016 - 1021
  • [38] Treatment options in lymph node-positive prostate cancer
    Swanson, GP
    Thompson, IM
    Basler, J
    CANCER, 2006, 106 (12) : 2531 - 2539
  • [39] Is node-positive prostate cancer always a systemic disease?
    Briganti, Alberto
    Chun, Felix K.
    Karakiewicz, Pierre I.
    Rigatti, Patrizio
    Montorsi, Francesco
    EUROPEAN UROLOGY, 2008, 54 (02) : 243 - 246
  • [40] Extranodal extension in lymph node-positive prostate cancer
    Cheng, L
    Pisansky, TM
    Ramnani, DM
    Leibovich, BC
    Cheville, JC
    Slezak, E
    Bergstralh, EJ
    Zincke, H
    Bostwick, DG
    MODERN PATHOLOGY, 2000, 13 (02) : 113 - 118
12345